$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)
Monteverde & Associates PC announced an investigation of Lifecore Biomedical (NASDAQ: LFCR) related to its pending sale to affiliates of Webster Equity Partners. The release is a plaintiff-law-firm solicitation asking whether the $6.28-per-share cash deal, plus a contingent value right tied to revenue and EBITDA milestones through 2030, is fair to shareholders.
Key figures
- Deal Value Usd
- $6.28 in cash per share
- Deal terms
- $6.28 cash per share plus one non-transferable contingent value right tied to revenue and EBITDA milestones through 2030
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.